MAGEA3 and cancer: The study by Demirović et al. [59] investigated the expression of MAGE-A3/4 and NY-ESO-1 in RO and ChRCC, finding significant differences in the expression of these cancer testis antigens between the two tumour types, which may have diagnostic implications.